Colgate-Palmolive

Free cash flow before dividends Net cash provided by operations less Capital expenditures.

SEC original ↗Colgate-Palmolive — Earnings release (8-K exhibit)EX-99Oct 31, 2025

As management uses free cash flow before dividends to evaluate the Company s ability to satisfy current and future obligations, pay dividends, fund future business opportunities and repurchase stock, the Company believes that it provides useful information to investors.

SEC original ↗Colgate-Palmolive — Earnings release (8-K exhibit)EX-99Oct 31, 2025

Free cash flow before dividends is not a measure of cash available for discretionary expenditures since the Company has certain non-discretionary obligations such as debt service that are not deducted from the measure.

SEC original ↗Colgate-Palmolive — Earnings release (8-K exhibit)EX-99Oct 31, 2025

See Condensed Consolidated Statements of Cash Flows for the nine months ended September 30, 2025 and 2024 for a comparison of free cash flow before dividends to Net cash provided by operations as reported in accordance with GAAP.

SEC original ↗Colgate-Palmolive — Earnings release (8-K exhibit)EX-99Oct 31, 2025

The acquisition was financed with a combination of debt and cash and was accounted for as a business combination in accordance with ASC 805.

SEC original ↗Colgate-Palmolive — 10-Q Quarterly report10-QJul 31, 2026

Volatility relating to these exposures is managed on a global basis by utilizing a number of techniques, including working capital management, sourcing strategies, selling price increases, selective borrowings in local currencies and entering into selective derivative instrument transactions, issued with standard features, in accordance with the Company s treasury and risk management policies, which prohibit the use of derivatives for speculative purposes and leveraged derivatives for any purpose.

SEC original ↗Colgate-Palmolive — 10-Q Quarterly report10-QJul 31, 2026

Noel Wallace, Chairman, President and Chief Executive Officer, commented on the Base Business third quarter results, We are pleased to have delivered another quarter of net sales and organic sales growth, even in the face of slowing category growth in many markets and the negative impact from lower private label pet sales as we have exited that non-strategic business.

SEC original ↗Colgate-Palmolive — Earnings release (8-K exhibit)EX-99Oct 31, 2025

As we transition to our new 2030 strategy and deploy our previously announced Strategic Growth and Productivity Program, we are well positioned to reaccelerate growth despite uncertainty in global markets and lower worldwide category growth.

SEC original ↗Colgate-Palmolive — Earnings release (8-K exhibit)EX-99Oct 31, 2025

The 2030 strategy is our blueprint for adapting to the challenges and capturing the opportunities of this more complex operating environment.

SEC original ↗Colgate-Palmolive — Earnings release (8-K exhibit)EX-99Oct 31, 2025

The Strategic Growth and Productivity Program will help ensure we have the organizational structure and support we need to achieve our goals in the near term and deliver consistent compounded earnings per share growth over the long term.

SEC original ↗Colgate-Palmolive — Earnings release (8-K exhibit)EX-99Oct 31, 2025

Focused on Oral Care, Personal Care, Home Care and Pet Nutrition, we sell our products in more than 200 countries and territories under brands such as Colgate, Palmolive, elmex, hello, meridol, Sorriso, Tom s of Maine, EltaMD, Filorga, Irish Spring, Lady Speed Stick, PCA SKIN, Protex, Sanex, Softsoap, Speed Stick, Ajax, Axion, Fabuloso, Murphy, Soupline and Suavitel, as well as Hill s Science Diet, Hill s Prescription Diet and Prime100.

SEC original ↗Colgate-Palmolive — Earnings release (8-K exhibit)EX-99Oct 31, 2025

As we transition to our new 2030 strategy and deploy our previously announced Strategic Growth and Productivity Program, we are well positioned to reaccelerate growth despite uncertainty in global markets and lower worldwide category growth.

SEC original ↗Colgate-Palmolive — Earnings release (8-K exhibit)EX-99Oct 31, 2025

The 2030 strategy is our blueprint for adapting to the challenges and capturing the opportunities of this more complex operating environment.

SEC original ↗Colgate-Palmolive — Earnings release (8-K exhibit)EX-99Oct 31, 2025

Full Year 2025 Guidance Based on current spot rates and including the estimated impact of tariffs announced and finalized as of October 29, 2025 The Company still expects net sales to be up low single digits, including a flat to low-single-digit negative impact from foreign exchange.

SEC original ↗Colgate-Palmolive — Earnings release (8-K exhibit)EX-99Oct 31, 2025

These statements are made, except as otherwise noted with respect to tariffs, on the basis of the Company s views and assumptions as of October 31, 2025.

SEC original ↗Colgate-Palmolive — Earnings release (8-K exhibit)EX-99Oct 31, 2025

Base Business operating results exclude, as applicable, charges resulting from the ERISA litigation matter and the 2022 Global Productivity Initiative and acquisition-related costs.

SEC original ↗Colgate-Palmolive — Earnings release (8-K exhibit)EX-99Oct 31, 2025

These non-GAAP financial measures exclude items that, either by their nature or amount, management would not expect to occur as part of the Company s normal business on a regular basis, such as restructuring charges, charges for certain litigation and tax matters, acquisition-related costs, gains and losses from certain divestitures and certain other unusual, non-recurring items.

SEC original ↗Colgate-Palmolive — Earnings release (8-K exhibit)EX-99Oct 31, 2025